Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Influx Healthtech IPO is a book build issue of ₹58.57 crores. The issue is a combination of fresh issue of 0.50 crore shares aggregating to ₹48.00 crores and offer for sale of 0.11 crore shares aggregating to ₹10.56 crores.
Influx Healthtech IPO bidding started from Jun 18, 2025 and ended on Jun 20, 2025. The allotment for Influx Healthtech IPO was finalized on Jun 23, 2025. The shares got listed on NSE SME on Jun 25, 2025.
Influx Healthtech IPO price band is set at ₹96.00 per share . The lot size for an application is 1,200. The minimum amount of investment required by an retail is ₹1,09,200 (1200 shares). The minimum lot size investment for HNI is 2 lots (2,400 shares), amounting to ₹2,30,400.
Rarever Financial Advisors Pvt.Ltd. is the book running lead manager and Maashitla Securities Pvt.Ltd. is the registrar of the issue. The market maker of the company is R.K.Stock Holding Pvt.Ltd..
Refer to Influx Healthtech IPO RHP for detailed Information.
| IPO Date | June 18, 2025 to June 20, 2025 |
| Listing Date | June 25, 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹91 to ₹96 per share |
| Issue Price Final | ₹96 per share |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 61,00,800 shares (aggregating up to ₹58.57 Cr) |
| Reserved for Market Maker | 3,06,000 shares R.K.Stock Holding Pvt.Ltd. (aggregating up to ₹2.94 Cr) |
| Fresh Issue (Ex Market Maker) | 46,94,400 shares (aggregating up to ₹45.07 Cr) |
| Offer for Sale | 11,00,400 shares of ₹10 (aggregating up to ₹10.56 Cr) |
| Net Offered to Public | 57,94,800 shares (aggregating up to ₹55.63 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,81,50,000 shares |
| Share Holding Post Issue | 2,31,50,400 shares |
Influx Healthtech IPO offers total 61,00,800 shares. Out of which 28,95,600 (47.46%) allocated to QIB, 11,59,200 (19.00%) allocated to QIB (Ex- Anchor), 8,70,000 (14.26%) allocated to NII, 20,29,200 (33.26%) allocated to RII and 17,36,400 (28.46%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 3,06,000 (5.02%) |
| QIB Shares Offered | 28,95,600 (47.46%) |
| − Anchor Investor Shares Offered | 17,36,400 (28.46%) |
| − QIB (Ex. Anchor) Shares Offered | 11,59,200 (19.00%) |
| NII (HNI) Shares Offered | 8,70,000 (14.26%) |
| Retail Shares Offered | 20,29,200 (33.26%) |
| Total Shares Offered | 61,00,800 (100.00%) |
Influx Healthtech IPO raises ₹16.67 crore from anchor investors. Influx Healthtech IPO Anchor bid date is June 17, 2025. Influx Healthtech IPO Anchor Investors list
| Bid Date | June 17, 2025 |
| Shares Offered | 17,36,400 |
| Anchor Portion Size (In Cr.) | 16.67 |
| Anchor lock-in period end date for 50% shares (30 Days) | July 23, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | September 21, 2025 |
Influx Healthtech IPO opens on June 18, 2025, and closes on June 20, 2025.
| IPO Open Date | Wed, Jun 18, 2025 |
| IPO Close Date | Fri, Jun 20, 2025 |
| Tentative Allotment | Mon, Jun 23, 2025 |
| Initiation of Refunds | Tue, Jun 24, 2025 |
| Credit of Shares to Demat | Tue, Jun 24, 2025 |
| Tentative Listing Date | Wed, Jun 25, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Jun 20, 2025 |
Investors can bid for a minimum of 1,200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,15,200 |
| Retail (Max) | 1 | 1,200 | ₹1,15,200 |
| HNI (Min) | 2 | 2,400 | ₹2,30,400 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries.
The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.
Product Portfolio:
The Company aids Nutraceutical and Cosmetic firms with product development and manufacturing. It offers end-to-end services, including development, production, and regulatory support, enabling clients to focus on formulation and commercialization.
As of June 11, 2025, the company has 163 permanent employees on a payroll basis.
Competitive Strength
Influx Healthtech Limited's revenue increased by 5% and profit after tax (PAT) rose by 19% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 70.30 | 41.10 | 28.30 |
| Total Income | 104.99 | 100.10 | 76.07 |
| Profit After Tax | 13.37 | 11.22 | 7.20 |
| Net Worth | 36.15 | 22.87 | 11.65 |
| Reserves and Surplus | 18.00 | 22.85 | 11.63 |
| Total Borrowing | 0.22 | 0.32 | 0.80 |
| Amount in ₹ Crore | |||
The market capitalization of Influx Healthtech IPO is ₹222.24 Cr.
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 36.98% |
| ROCE | 49.17% |
| Debt/Equity | 0.01 |
| RoNW | 36.98% |
| PAT Margin | 12.75% |
| EBITDA Margin | 19.62% |
| Price to Book Value | 4.82 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 7.36 | 5.77 |
| P/E (x) | 13.04 | 16.63 |
The Company Influx Healthtech IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division | 22.60 |
| 2 | Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division | 11.59 |
| 3 | Purchase of Machineries for Homecare and Cosmetic Division | 2.76 |
| 4 | General corporate purposes | 5.44 |
[Dilip Davda] IHL operates as CDMO for healthcare products with its three units. It marked steady progress in its top lines for the reported periods. The sudden boost in its bottom lines for FY24 and FY25 raise eyebrows and concern over its sustainability going forward as it is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears fully priced. Well-informed/cash surplus investors may park moderate funds for medium term. Read detail review...
| Listing Date | June 25, 2025 |
| BSE Script Code | |
| NSE Symbol | INFLUX |
| ISIN | INE0MYZ01012 |
| Final Issue Price | ₹96 per share |
| NSE Listing Group | ST (Trade to Trade) |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹96.00 |
| Open | ₹132.50 |
| Low | ₹125.90 |
| High | ₹135.85 |
| Last Trade | ₹126.20 |
Influx Healthtech Ltd.
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra, 400067
Phone: +91 7045997809
Email: cs@influxhealthtech.com
Website: https://influxhealthtech.com/
Maashitla Securities Pvt.Ltd.
Phone: +91-11-45121795-96
Email: investor.ipo@maashitla.com
Website: https://maashitla.com/allotment-status/public-issues
Influx Healthtech IPO is a SME IPO of 61,00,800 equity shares of the face value of ₹10 aggregating up to ₹58.57 Crores. The issue is priced at ₹96 per share. The minimum order quantity is 1200.
The IPO opens on June 18, 2025, and closes on June 20, 2025.
Maashitla Securities Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Influx Healthtech IPO using UPI as a payment gateway. Zerodha customers can apply in Influx Healthtech IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Influx Healthtech IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Influx Healthtech IPO opens on June 18, 2025 and closes on June 20, 2025.
Influx Healthtech IPO lot size is 1200, and the minimum amount required for application is ₹1,15,200.
You can apply in Influx Healthtech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Influx Healthtech IPO will be done on Monday, June 23, 2025, and the allotted shares will be credited to your demat account by Tuesday, June 24, 2025. Check the Influx Healthtech IPO allotment status.
The Influx Healthtech IPO listing date is on Wednesday, June 25, 2025.
Useful Articles
RHP